Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMS: Ranolazine in CAD and Metabolic Syndrome
NCT01304095Phase 4Unknown
- Sponsor
- Atlanta Heart Specialists
- Start
- Jan 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in coronary artery disease (CAD), Angina Pectoris (AP), sponsored by Atlanta Heart Specialists. Status: unknown.
02
Drugs
ranolazine
03
Conditions
coronary artery disease (CAD)Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT01304095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304095.